Our top pick for
UBS Group AG is a banks-diversified business based in the US. UBS Group shares (UBS) are listed on the NYSE and all prices are listed in US Dollars. UBS Group employs 71,304 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$17.21|
|52-week range||$10.93 - $17.35|
|50-day moving average||$16.40|
|200-day moving average||$16.03|
|Wall St. target price||$18.56|
|Dividend yield||$0.37 (2.16%)|
|Earnings per share (TTM)||$2.05|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-12)||2.99%|
|1 month (2021-09-17)||5.00%|
|3 months (2021-07-19)||18.36%|
|6 months (2021-04-19)||7.97%|
|1 year (2020-10-19)||46.47%|
|2 years (2019-10-18)||51.63%|
|3 years (2018-10-19)||24.35%|
|5 years (2016-10-19)||25.53%|
Valuing UBS Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of UBS Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
UBS Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, UBS Group shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
UBS Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0039. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into UBS Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$34.7 billion|
|Operating margin TTM||27.4%|
|Gross profit TTM||$32.4 billion|
|Return on assets TTM||0.7%|
|Return on equity TTM||13.04%|
|Market capitalisation||$60.1 billion|
TTM: trailing 12 months
There are currently 7.1 million UBS Group shares held short by investors – that's known as UBS Group's "short interest". This figure is 15.3% up from 6.2 million last month.
There are a few different ways that this level of interest in shorting UBS Group shares can be evaluated.
UBS Group's "short interest ratio" (SIR) is the quantity of UBS Group shares currently shorted divided by the average quantity of UBS Group shares traded daily (recently around 1.9 million). UBS Group's SIR currently stands at 3.78. In other words for every 100,000 UBS Group shares traded daily on the market, roughly 3780 shares are currently held short.
However UBS Group's short interest can also be evaluated against the total number of UBS Group shares, or, against the total number of tradable UBS Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case UBS Group's short interest could be expressed as 0% of the outstanding shares (for every 100,000 UBS Group shares in existence, roughly 0 shares are currently held short) or 0.0021% of the tradable shares (for every 100,000 tradable UBS Group shares, roughly 2 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against UBS Group.
Find out more about how you can short UBS Group stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like UBS Group.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 27.02
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and UBS Group's overall score of 27.02 (as at 12/31/2018) is pretty good – landing it in it in the 39th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like UBS Group is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 3.41/100
UBS Group's environmental score of 3.41 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that UBS Group is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 14.25/100
UBS Group's social score of 14.25 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that UBS Group is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 10.36/100
UBS Group's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that UBS Group is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. UBS Group scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that UBS Group hasn't always managed to keep its nose clean.
|Total ESG score||27.02|
|Total ESG percentile||39.22|
|Environmental score percentile||3|
|Social score percentile||3|
|Governance score percentile||3|
|Level of controversy||3|
Dividend payout ratio: 36.16% of net profits
Recently UBS Group has paid out, on average, around 36.16% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.16% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), UBS Group shareholders could enjoy a 2.16% return on their shares, in the form of dividend payments. In UBS Group's case, that would currently equate to about $0.37 per share.
While UBS Group's payout ratio might seem fairly standard, it's worth remembering that UBS Group may be investing much of the rest of its net profits in future growth.
UBS Group's most recent dividend payout was on 14 April 2021. The latest dividend was paid out to all shareholders who bought their shares by 12 April 2021 (the "ex-dividend date").
UBS Group's shares were split on a 2:1 basis on 9 July 2006. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your UBS Group shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for UBS Group shares which in turn could have impacted UBS Group's share price.
Over the last 12 months, UBS Group's shares have ranged in value from as little as $10.9258 up to $17.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while UBS Group's is 1.1193. This would suggest that UBS Group's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
UBS Group AG, together with its subsidiaries, provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through four divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, and Investment Bank. The Global Wealth Management division offers investment advice and solutions, as well as lending solutions, to ultra high net worth and high net worth clients. This segment also provides wealth planning, investing, philanthropy, corporate and banking services, and family advisory services, as well as mortgage, securities-based, and structured lending solutions. The Personal & Corporate Banking division provides banking products and services, such as deposits, cards, and online and mobile banking, as well as lending, investments, and retirement services. The Asset Management division offers equities, fixed income, hedge funds, real estate and private markets, indexed and alternative beta strategies, asset allocation and currency investment strategies, customized multi-asset solutions, advisory and fiduciary services, and multi-manager hedge fund solutions and advisory services. The Investment Bank division advises clients on strategic business opportunities and helps them raise capital to fund their activities; enables its clients to buy, sell, and finance securities on capital markets and to manage their risks and liquidity; and offers clients differentiated content on major financial markets and securities.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.